Allevion Therapeutics

Private

Irvine, CaliforniaHealthcare & Life Scienceshttps://www.alleviontx.com/

Last Round

VC Round

Sep 23, 2020

Company Overview

Allevion Therapeutics is a health care company that develops non-invasive, wearable neuromodulation devices for the treatment of movement disorders such as essential tremor.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

neuromodulationwearable medical deviceessential tremor treatmentParkinson's diseasemedtechhealth IoTnon-invasive therapytremor reliefdigital healthremote patient monitoringRPMwearable techmovement disordersmart-bandbioelectronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allevion Therapeutics Comparables

Compare Allevion Therapeutics with similar companies based on industry and business-model similarity.

Allevion Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Encora Therapeutics	89%
Fasikl, Inc.	84%
Cala Health	82%

View all Comparables

Allevion Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Sep 23, 2020
Series A	Jul 9, 2019
Seed	May 9, 2018

View all Funding Rounds

Allevion Therapeutics Investors

Notable investors and investment history

Allevion Therapeutics investors
Investor	Rounds
Adventus Ventures	VC Round, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 23, 2020
Adventus Ventures participated in the VC Round.

View all signals

Allevion Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Allevion Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allevion Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersIrvine, California

Employee Range3

Year Founded2019

Last FundingSep 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.